Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.063 0.09
mRNA ML320 CTRPv2 pan-cancer AAC -0.06 0.1
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.1
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.1
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC -0.14 0.1
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.057 0.1
mRNA Axitinib CTRPv2 pan-cancer AAC -0.056 0.1
mRNA PIK-93 GDSC1000 pan-cancer AAC -0.048 0.1
mRNA necrostatin-7 CTRPv2 pan-cancer AAC 0.061 0.1
mRNA TAE684 CCLE pan-cancer AAC -0.073 0.1
Download CSV